Germany's drug regulatory body is attacked

BMJ 2006; 333 doi: (Published 23 November 2006) Cite this as: BMJ 2006;333:1087
  1. Annette Tuffs
  1. 1Heidelberg

    The independent institute that assesses new drugs in Germany is facing criticisms similar to those aimed at its equivalent body in the United Kingdom, the National Institute for Health and Clinical Excellence.

    Last week in Cologne a member of an association for people with diabetes and representatives of the drug industry walked out of a hearing of the Institute for Quality and Economic Efficiency in Health Care in Cologne because they were not allowed to record the hearing, which was on the use of short acting insulin analogues.

    The institute has provoked anger among patients' groups and the drug industry by saying that no evidence has been …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription